Prothena (PRTA) Stock Chart & Stock Price History → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free PRTA Stock Alerts $19.95 -0.09 (-0.45%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prothena Stock Price Performance5 Day Performance-0.75%1 Month Performance-4.41%3 Month Performance-31.16%6 Month Performance-38.58%Year-To-Date Performance-45.10%1 Year Performance-69.97% Receive PRTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. PRTA Stock Chart for Tuesday, May, 28, 2024 PRTA Chart by TradingView Prothena Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$20.04$19.95-0.45%$20.54$19.78583,739 shs$1.07 billion05/27/2024$20.04$20.04$20.34$19.89333,000 shs$1.08 billion05/24/2024$20.10$20.04-0.30%$20.34$19.89333,008 shs$1.08 billion05/23/2024$21.59$20.10-6.90%$21.66$19.78584,359 shs$1.08 billion05/22/2024$21.65$21.59-0.28%$22.22$21.34370,817 shs$1.16 billion05/21/2024$22.63$21.65-4.33%$22.62$21.25289,960 shs$1.16 billion Get the Latest News and Ratings for PRTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$22.52$22.63+0.49%$22.91$22.23245,345 shs$1.22 billion05/17/2024$23.39$22.52-3.72%$23.62$22.37423,160 shs$1.21 billion05/16/2024$22.39$23.39+4.47%$23.49$21.79493,717 shs$1.26 billion05/15/2024$20.68$22.39+8.27%$22.44$20.98454,586 shs$1.20 billion05/14/2024$20.71$20.68-0.14%$21.91$20.31501,929 shs$1.11 billion05/13/2024$21.34$20.71-2.95%$21.83$20.65745,608 shs$1.11 billion05/10/2024$22.00$21.34-3.00%$22.90$21.31454,300 shs$1.15 billion05/09/2024$23.03$22.00-4.47%$22.79$21.09634,713 shs$1.18 billion05/08/2024$23.54$23.03-2.17%$23.87$22.70629,432 shs$1.24 billion05/07/2024$23.74$23.54-0.84%$24.20$23.29559,154 shs$1.26 billion05/06/2024$22.93$23.74+3.53%$24.03$22.90519,569 shs$1.28 billion05/03/2024$22.04$22.93+4.04%$23.70$22.74653,661 shs$1.23 billion05/02/2024$21.42$22.04+2.89%$22.40$21.51530,194 shs$1.18 billion05/01/2024$20.34$21.42+5.31%$22.00$20.26708,995 shs$1.15 billion04/30/2024$21.19$20.34-4.01%$21.19$20.26530,345 shs$1.09 billion04/29/2024$20.87$21.19+1.53%$22.09$20.91600,639 shs$1.14 billion04/26/2024$20.56$20.87+1.51%$21.18$20.34369,975 shs$1.12 billion04/25/2024$20.56$20.56$20.67$19.65496,352 shs$1.10 billion04/24/2024$20.56$20.56$20.88$20.32341,791 shs$1.10 billion04/23/2024$21.29$20.56-3.43%$21.70$20.44442,704 shs$1.10 billion04/22/2024$21.16$21.29+0.61%$21.79$20.87356,639 shs$1.14 billion04/19/2024$20.57$21.16+2.87%$21.18$20.42508,532 shs$1.14 billion04/18/2024$21.00$20.57-2.05%$21.26$20.44567,688 shs$1.11 billion04/17/2024$21.34$21.00-1.59%$21.70$20.95465,510 shs$1.13 billion04/16/2024$21.99$21.34-2.96%$22.14$21.06479,715 shs$1.15 billion04/15/2024$22.24$21.99-1.12%$22.44$21.59530,668 shs$1.18 billion04/12/2024$23.28$22.24-4.47%$23.30$21.92526,230 shs$1.19 billion04/11/2024$22.82$23.28+2.02%$23.99$22.21599,106 shs$1.25 billion04/10/2024$23.54$22.82-3.06%$22.93$21.90528,120 shs$1.23 billion04/09/2024$23.68$23.54-0.59%$24.08$22.93464,441 shs$1.26 billion04/08/2024$23.37$23.68+1.33%$24.07$23.39301,269 shs$1.27 billion04/05/2024$23.26$23.37+0.47%$23.82$22.23471,664 shs$1.26 billion04/04/2024$24.26$23.26-4.12%$25.12$22.88760,812 shs$1.25 billion04/03/2024$23.95$24.26+1.29%$24.36$23.23614,986 shs$1.30 billionNvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately.04/02/2024$26.15$23.95-8.41%$25.36$23.89776,386 shs$1.29 billion04/01/2024$24.77$26.15+5.57%$26.36$24.52616,646 shs$1.40 billion03/29/2024$24.77$24.77$25.34$24.25803,163 shs$1.33 billion03/28/2024$25.16$24.77-1.55%$25.34$24.29803,163 shs$1.33 billion03/27/2024$24.75$25.16+1.66%$25.57$24.46612,086 shs$1.35 billion03/26/2024$25.40$24.75-2.56%$25.87$24.53612,779 shs$1.33 billion03/25/2024$25.92$25.40-2.01%$26.27$24.71393,071 shs$1.36 billion03/22/2024$25.59$25.92+1.29%$26.37$25.18942,937 shs$1.39 billion03/21/2024$25.51$25.59+0.31%$26.45$25.28463,594 shs$1.37 billion03/20/2024$25.09$25.51+1.67%$25.86$24.47423,130 shs$1.37 billion03/19/2024$25.09$25.09$25.59$24.81419,556 shs$1.35 billion03/18/2024$26.07$25.09-3.76%$26.75$24.62689,827 shs$1.35 billion03/15/2024$26.48$26.07-1.55%$26.75$25.941.54 million shs$1.40 billion03/14/2024$28.60$26.48-7.41%$28.53$26.24669,692 shs$1.42 billion03/13/2024$27.54$28.60+3.85%$29.00$27.53489,640 shs$1.54 billion03/12/2024$28.06$27.54-1.85%$28.24$27.05481,789 shs$1.48 billion03/11/2024$30.22$28.06-7.15%$30.85$27.89568,771 shs$1.51 billion03/08/2024$29.30$30.22+3.14%$30.51$29.43366,940 shs$1.62 billion03/07/2024$29.34$29.30-0.14%$29.68$29.10390,080 shs$1.57 billion03/06/2024$28.35$29.34+3.49%$29.44$28.55412,554 shs$1.58 billion03/05/2024$28.32$28.35+0.11%$28.57$27.52328,382 shs$1.52 billion03/04/2024$28.53$28.32-0.74%$29.33$27.83338,043 shs$1.52 billion03/01/2024$27.59$28.53+3.41%$28.92$27.69607,073 shs$1.53 billion02/29/2024$28.98$27.59-4.80%$29.76$27.54749,471 shs$1.48 billion02/28/2024$30.30$28.98-4.36%$30.36$28.91642,222 shs$1.56 billion02/27/2024$28.18$30.30+7.52%$31.01$28.38827,183 shs$1.63 billion Related Companies: AbCellera Biologics Stock Chart Collegium Pharmaceutical Stock Chart Gyre Therapeutics Stock Chart Mirum Pharmaceuticals Stock Chart Arcutis Biotherapeutics Stock Chart Enliven Therapeutics Stock Chart Cassava Sciences Stock Chart Ironwood Pharmaceuticals Stock Chart MannKind Stock Chart Day One Biopharmaceuticals Stock Chart Receive PRTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRTA) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prothena Co. plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.